Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects

Henk J Blom, Yvo Smulders, Henk J Blom, Yvo Smulders

Abstract

This overview addresses homocysteine and folate metabolism. Its functions and complexity are described, leading to explanations why disturbed homocysteine and folate metabolism is implicated in many different diseases, including congenital birth defects like congenital heart disease, cleft lip and palate, late pregnancy complications, different kinds of neurodegenerative and psychiatric diseases, osteoporosis and cancer. In addition, the inborn errors leading to hyperhomocysteinemia and homocystinuria are described. These extreme human hyperhomocysteinemia models provide knowledge about which part of the homocysteine and folate pathways are linked to which disease. For example, the very high risk for arterial and venous occlusive disease in patients with severe hyperhomocysteinemia irrespective of the location of the defect in remethylation or transsulphuration indicates that homocysteine itself or one of its "direct" derivatives is considered toxic for the cardiovascular system. Finally, common diseases associated with elevated homocysteine are discussed with the focus on cardiovascular disease and neural tube defects.

Figures

Fig. 1
Fig. 1
Schematic representation of the folate cycles and homocysteine metabolism. AdoHcy S-adenosylhomocysteine, AdoMet S-adenosylmethionine, AICAR 5-aminoimidazole-4-carboxamide ribonucleotode, SAHH S-adenosylhomocysteine hydrolase, ATP adenosine triphosphate, BHMT betaine-homocysteine methyltransferase, CBS cystathionine β-synthase, CTH cystathionine γ-lyase, DHF dihydrofolate, DHFR dihydrofolate reductase, dUMP deoxyuridine monophosphate, dTMP deoxythymidine monophosphate, FAICAR formyl-AICAR, MAT methionine-adenosyltransferase, MTHFD methylenetetrahydrofolate dehydrogenase / methenyltetrahydrofolate cyclohydrolase / formyltetrahydrofolate synthetase, MTHFR methylenetetrahydrofolate reductase, MTR methionine synthase, MTRR methionine synthase reductase, SHMT serine-hydroxymethyltransferase, THF tetrahydrofolate, TYMS thymidylate synthase
Fig. 2
Fig. 2
Schematic overview of folate uptake and transport from the intestine, via the blood, into the cell. THF tetrahydrofolate, FR-α folate receptor alpha, PCFT proton-coupled folate transporter, RFC1 reduced folate carrier, THF tetrahydrofolate, FGCP folylpoly-γ-glutamate carboxypeptidase

References

    1. Afman LA, Blom HJ, Drittij MJ, Brouns MR, van Straaten HW. Inhibition of transmethylation disturbs neurulation in chick embryos. Brain Res Dev Brain Res. 2005;158:59–65. doi: 10.1016/j.devbrainres.2005.06.002.
    1. Al-Gazali LI, Padmanabhan R, Melnyk S, et al. Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am J Med Genet. 2001;103:128–132. doi: 10.1002/ajmg.1509.
    1. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA. 1998;95:13217–13220. doi: 10.1073/pnas.95.22.13217.
    1. Barber RC, Lammer EJ, Shaw GM, Greer KA, Finnell RH. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab. 1999;66:1–9. doi: 10.1006/mgme.1998.2787.
    1. Blom HJ. Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol. 2009;85:295–302. doi: 10.1002/bdra.20581.
    1. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat Rev Neurosci. 2006;7:724–731. doi: 10.1038/nrn1986.
    1. Castro R, Rivera I, Ravasco P, et al. 5, 10-methylenetetrahydrofolate reductase (MTHFR) 677C–>T and 1298A–>C mutations are associated with DNA hypomethylation. J Med Genet. 2004;41:454–458. doi: 10.1136/jmg.2003.017244.
    1. Chandler CJ, Harrison DA, Buffington CA, Santiago NA, Halsted CH. Functional specificity of jejunal brush-border pteroylpolyglutamate hydrolase in pig. Am J Physiol. 1991;260:G865–G872.
    1. Coelho CN, Klein NW. Methionine and neural tube closure in cultured rat embryos: morphological and biochemical analyses. Teratology. 1990;42:437–451. doi: 10.1002/tera.1420420412.
    1. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832–1835. doi: 10.1056/NEJM199212243272602.
    1. Dean W, Lucifero D, Santos F. DNA methylation in mammalian development and disease. Birth Defects Res C Embryo Today. 2005;75:98–111. doi: 10.1002/bdrc.20037.
    1. Dunlevy LP, Burren KA, Mills K, Chitty LS, Copp AJ, Greene ND. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol. 2006;76:544–552. doi: 10.1002/bdra.20286.
    1. Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med. 2007;45:1694–1699. doi: 10.1515/CCLM.2007.341.
    1. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99:5606–5611. doi: 10.1073/pnas.062066299.
    1. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113. doi: 10.1038/ng0595-111.
    1. Garrow TA, Brenner AA, Whitehead VM, et al. Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization. J Biol Chem. 1993;268:11910–11916.
    1. Hum DW, Bell AW, Rozen R, MacKenzie RE. Primary structure of a human trifunctional enzyme. Isolation of a cDNA encoding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase. J Biol Chem. 1988;263:15946–15950.
    1. Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 2004;56:1085–1097. doi: 10.1016/j.addr.2004.01.002.
    1. Kotb M, Mudd SH, Mato JM, et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 1997;13:51–52. doi: 10.1016/S0168-9525(97)01013-5.
    1. Leclerc D, Wilson A, Dumas R, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA. 1998;95:3059–3064. doi: 10.1073/pnas.95.6.3059.
    1. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet. 1996;5:1851–1858. doi: 10.1093/hmg/5.12.1851.
    1. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev CD006612
    1. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265–280. doi: 10.1016/S0163-7258(96)00197-0.
    1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128.
    1. Moephuli SR, Klein NW, Baldwin MT, Krider HM. Effects of methionine on the cytoplasmic distribution of actin and tubulin during neural tube closure in rat embryos. Proc Natl Acad Sci USA. 1997;94:543–548. doi: 10.1073/pnas.94.2.543.
    1. Mudd SH, Cantoni GL. Activation of methionine for transmethylation. III. The methionine-activating enzyme of Bakers’ yeast. J Biol Chem. 1958;231:481–492.
    1. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257. doi: 10.1016/S0092-8674(00)81656-6.
    1. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr. 2007;85:285S–288S.
    1. Qiu A, Jansen M, Sakaris A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127:917–928. doi: 10.1016/j.cell.2006.09.041.
    1. Quere I, Paul V, Rouillac C, et al. Spatial and temporal expression of the cystathionine beta-synthase gene during early human development. Biochem Biophys Res Commun. 1999;254:127–137. doi: 10.1006/bbrc.1998.9079.
    1. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–1093. doi: 10.1126/science.1063443.
    1. Smithells RW, Sheppard S, Schorah CJ. Vitamin dificiencies and neural tube defects. Arch Dis Child. 1976;51:944–950. doi: 10.1136/adc.51.12.944.
    1. Sunden SL, Renduchintala MS, Park EI, Miklasz SD, Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys. 1997;345:171–174. doi: 10.1006/abbi.1997.0246.
    1. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–332.
    1. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070–1071. doi: 10.1016/S0140-6736(95)91743-8.
    1. Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991;338:131–137. doi: 10.1016/0140-6736(91)90133-A.
    1. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369:1876–1882. doi: 10.1016/S0140-6736(07)60854-X.
    1. Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol. 1992;44:1898–1901. doi: 10.1016/0006-2952(92)90089-2.
    1. Yap S, Boers GH, Wilcken B, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21:2080–2085. doi: 10.1161/hq1201.100225.
    1. Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol. 2006;76:230–236. doi: 10.1002/bdra.20240.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir